Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

BACKGROUND: More than half of patients with colorectal cancer (CRC) present with metastatic disease or develop recurrent disease on first-line and second-line options. Treatment beyond the second line remains an area of unmet need for patients with progressive or recurrent disease. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Haque, Emaan, Muhsen, Ibrahim N., Esmail, Abdullah, Umoru, Godsfavour, Mylavarapu, Charisma, Ajewole, Veronica B., Abdelrahim, Maen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822717/
https://www.ncbi.nlm.nih.gov/pubmed/36620581
http://dx.doi.org/10.3389/fonc.2022.992455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822717/
https://www.ncbi.nlm.nih.gov/pubmed/36620581
http://dx.doi.org/10.3389/fonc.2022.992455

Ejemplares similares